Ticagrelor vs Clopidogrel for Patients Undergoing Endovascular Flow Diversion for Unruptured Intracranial Aneurysms: A Multicenter Investigation
American Journal of Neuroradiology · 2026-09 · 47 (9) · 2328-2333
DOI: 10.3174/ajnr.a9257 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Neuroradiology, online erschienen am 23.02.2026. Verfasst von Huanwen Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Neurology (H.C.), MedStar Georgetown University Hospital, Washington DC Alvin.huanwen.chen@gmail.com. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Ticagrelor, Clopidogrel, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of General Medical Sciences of the National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND AND PURPOSE: Dual antiplatelet therapy is essential for patients undergoing flow diversion (FD) for unruptured intracranial aneurysms (UIA), but the optimal P2Y12 inhibitor, particularly ticagrelor versus clopidogrel, remains controversial. This study aims to assess the comparative effectiveness of ticagrelor and clopidogrel for patients undergoing FD treatment for UIAs. MATERIALS AND METHODS: We performed a retrospective propensity score matched analysis using the TrinetX platform, which contains a multicenter database of real-world clinical records. Adult patients with UIA (ICD-10-CM: I67.1) who underwent FD and were initiated on either ticagrelor or clopidogrel within 14 days before to 3 days after FD placement were included. The primary end point was ischemic stroke, and secondary end points included major hemorrhage (intracranial hemorrhage [ICH] or hospitalization requiring blood transfusion), ICH, and all-cause mortality at 180 days. Propensity score matching was performed to balance baseline characteristics. Log-rank tests and Cox proportional hazard models were used to compare outcomes between groups. RESULTS: The study included 2976 patients (1047 ticagrelor, 1929 clopidogrel). After propensity score matching, 963 patients remained in each group. At 180 days, ischemic stroke rates were similar between the ticagrelor and clopidogrel groups (1.3% versus 1.3%, P = 1.00; hazard ratio [HR], 1.00 [95% CI 0.45-2.23]). Major hemorrhage rates were numerically higher for ticagrelor patients (2.4% versus 2.0%, P = .52; HR, 1.23 [95% CI, 0.66-2.28]), as were ICH rates (1.4% versus 0.8%, P = .18; HR, 1.86 [95% CI, 0.74-4.67]). All-cause mortality was significantly higher in the ticagrelor group (1.7% versus 0.6%, P = .025; HR, 3.01 [95% CI, 1.10-8.29]). CONCLUSIONS: In real-world practice, ticagrelor and clopidogrel for patients undergoing FD were equivalent in terms of ischemic stroke and hemorrhage risks, though ticagrelor was associated with a significantly higher risk of all-cause mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Neurology (H.C.), MedStar Georgetown University Hospital, Washington DC Alvin.huanwen.chen@gmail.com.
- Department of Neuroradiology (D.A.L.), West Virginia University, Morgantown, West Virginia.
- Department of Interventional Radiology (M.C.), Oregon Health & Science University, Portland, Oregon.
- Department of Radiology (A.M.), Yale New Haven Hospital, New Haven, Connecticut.
- Department of Radiology, (D.G.), University of Maryland Medical Center, Baltimore, Maryland.
- Department of Neurosurgery (D.G.), University of Maryland Medical Center, Baltimore, Maryland.
ORCID-Profile: Dhairya A Lakhani, Ajay Malhotra, Dheeraj Gandhi
Förderung
- National Institute of General Medical Sciences of the National Institutes of Health
Zitieren
APA
Chen, H., Lakhani, D. A., Colasurdo, M., Malhotra, A., & Gandhi, D. (2026). Ticagrelor vs Clopidogrel for Patients Undergoing Endovascular Flow Diversion for Unruptured Intracranial Aneurysms: A Multicenter Investigation. American Journal of Neuroradiology, 47(9), 2328-2333. https://doi.org/10.3174/ajnr.a9257
Vancouver
Chen H, Lakhani DA, Colasurdo M, Malhotra A, Gandhi D. Ticagrelor vs Clopidogrel for Patients Undergoing Endovascular Flow Diversion for Unruptured Intracranial Aneurysms: A Multicenter Investigation. American Journal of Neuroradiology. 2026;47(9):2328-2333. doi:10.3174/ajnr.a9257
BibTeX
@article{Chen2026,
author = {Chen, Huanwen and Lakhani, Dhairya A and Colasurdo, Marco and Malhotra, Ajay and Gandhi, Dheeraj},
title = {Ticagrelor vs Clopidogrel for Patients Undergoing Endovascular Flow Diversion for Unruptured Intracranial Aneurysms: A Multicenter Investigation},
journal = {American Journal of Neuroradiology},
year = {2026},
volume = {47},
number = {9},
pages = {2328--2333},
doi = {10.3174/ajnr.a9257}
}
EUVIMED